Actively Recruiting

Age: 1Month - 16Years
All Genders
NCT06371170

Rivaroxaban for Intracardiac Thrombosis in the Pediatric Population

Led by Azienda Ospedaliero, Universitaria Ospedali Riuniti · Updated on 2024-04-19

20

Participants Needed

1

Research Sites

208 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

The goal of this observational study is to determine the efficacy of rivaroxaban treatment for intracardiac thrombi resolution in pediatric patients (\< 16 years old) diagnosed with intracardiac thrombosis. The main question it aims to answer is: Does rivaroxaban treatment resolve the thrombosis during a 3-month treatment? Participants already taking rivaroxaban as part of their regular medical care for thrombosis resolution. They will undergo monthly visits to check that the treatment is progressing correctly and that no major bleeding has occurred. After 3 months of treatment, they will repeat the radiological imaging investigation to verify the actual resolution of the thrombosis.

CONDITIONS

Official Title

Rivaroxaban for Intracardiac Thrombosis in the Pediatric Population

Who Can Participate

Age: 1Month - 16Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Intracardiac thrombosis confirmed by echocardiography and cardiac MRI or CT scan
  • Informed consent given by parents or legal guardians
Not Eligible

You will not qualify if you...

  • Born before 38 weeks of gestation
  • Oral feeding for less than 10 days or body weight below 2.6 kg
  • Any major or clinically relevant bleeding event or abnormal coagulation test results within 10 days before enrollment

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

CCPC

Ancona, The Marches, Italy, 60123

Actively Recruiting

Loading map...

Research Team

F

Francesco Bianco, M.D., Ph.D.

CONTACT

V

Valentina Bucciarelli, M.D., Ph.D.

CONTACT

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

0

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here

Rivaroxaban for Intracardiac Thrombosis in the Pediatric Population | DecenTrialz